Document is current
Any future updates will be listed below
-
Authors
Álvarez-Cubela, Silvia
Altilio, Isabella D. https://orcid.org/0000-0002-1153-1785
Doke, Mayur
Klein, Dagmar
Tamayo, Alejandro https://orcid.org/0000-0002-4801-8125
Alcázar, Óscar
Santana, Carlos García
Qadir, Mirza Muhammad Fahd https://orcid.org/0000-0002-6764-6151
Alver, Charles García https://orcid.org/0000-0003-1195-454X
Cruz, Francis
Biggs, Olivia
Tovar Castro, Jorge David https://orcid.org/0000-0002-0810-4379
Navarro-Rubio, Belén
Ricordi, Camillo
Caicedo, Alejandro https://orcid.org/0000-0002-3765-3529
Buchwald, Peter https://orcid.org/0000-0003-2732-8180
Agarwal, Ashutosh
Oltra, Elisa
Pastori, Ricardo Luis
Domínguez-Bendala, Juan https://orcid.org/0000-0001-9410-9143
- License Information
-
More Information
Article History
Received: 23 November 2024
Accepted: 22 June 2025
First Online: 3 July 2025
Competing interests
: Drs. Domínguez-Bendala, Pastori and Ricordi are named inventors in the patent titled: Compositions, Systems and Methods for Obtaining Insulin-Producing Cells, U.S. Patent No. 11,466,255 B2 (October 11, 2022). Drs. Domínguez-Bendala and Ricordi are also named inventors in the patents titled: Enhanced Oxygen Cell Culture Platforms; Patent number: 8,551,770 (July 11, 2013); and Enhanced Oxygen Cell Culture Platforms (CIP), Patent number: 9,175,254 (September 17, 2015). The University of Miami and Dr. Juan Domínguez-Bendala et al. hold the rights to intellectual property used in the study and may financially benefit from the commercialization of the intellectual property. All other authors declare no competing interests.
